NCT00322868 Safety and Efficacy of Pioglitazone as an Anti-inflammatory for the Treatment of Cystic Fibrosis (CF) Lung Disease Status COMPLETED Phase NA
NCT00311506 A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease Status COMPLETED Phase N/A
NCT00308958 Comparison of Airway Clearance Efficacy of Two High Frequency Chest Wall Oscillation (HFCWO) Devices in Cystic Fibrosis Status COMPLETED Phase NA
NCT00308243 Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. Status COMPLETED Phase PHASE1
NCT00298922 Azithromycin in Patients With CF, Infected With Burkholderia Cepacia Complex Status UNKNOWN Phase PHASE2
NCT00297167 Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency Status COMPLETED Phase PHASE3
NCT00287443 Metabolic Abnormalities in Hispanic Children With Cystic Fibrosis Status WITHDRAWN Phase NA
NCT00287430 Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis Status WITHDRAWN Phase NA
NCT00274391 Efficacy of Amiloride and Hypertonic Saline in Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT00274313 Safety Study of Inhaled 552-02 in Cystic Fibrosis Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00271310 The Effects of Long Term Inhalation of Hypertonic Saline in Subjects With Cystic Fibrosis Status COMPLETED Phase PHASE3
NCT00265434 Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis Status COMPLETED Phase PHASE3
NCT00256555 Growth Hormone Treatment Study in Children With Cystic Fibrosis Status WITHDRAWN Phase PHASE2/PHASE3
NCT00248755 Assessing Mucociliary Clearance and Airway Liquid Volume in the CF Airway Status COMPLETED Phase NA
NCT00244270 Cystic Fibrosis and Totally Implantable Vascular Access Devices Status COMPLETED Phase PHASE4
NCT00241969 Behavioral & Nutritional Treatment to Help CF Preschoolers Grow Status COMPLETED Phase NA